Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma

IMPORTANCE: Although the number of treatments for elderly patients with non–transplant-eligible (NTE) multiple myeloma (MM) has increased substantially, evidence is lacking on the clinical effectiveness and cost-effectiveness of novel treatment sequences. OBJECTIVE: To determine the optimal sequence...

Descripción completa

Detalles Bibliográficos
Autores principales: Blommestein, Hedwig M., Franken, Margreet G., van Beurden-Tan, Chrissy H. Y., Blijlevens, Nicole M. A., Huijgens, Peter C., Sonneveld, Pieter, Uyl-de Groot, Carin A., Zweegman, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008287/
https://www.ncbi.nlm.nih.gov/pubmed/33779744
http://dx.doi.org/10.1001/jamanetworkopen.2021.3497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008287/
https://www.ncbi.nlm.nih.gov/pubmed/33779744
http://dx.doi.org/10.1001/jamanetworkopen.2021.3497

Ejemplares similares